Mangalam Drugs and Organics share news, announcements and annual reports
NSE: MANGALAMBSE: 532637Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹29.22.
30 Oct: open ₹29.48, high ₹29.75, low ₹28.51
- Under NSE's long-term additional surveillance, stage I, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 5 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹45 Cr3,423rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.44
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −30.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −12.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.02
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 50,07391.9% delivered
Mangalam Drugs and Organics has 527 announcements on record, routine notices left out; 2 in the 30 days to 1 Nov 2026, the latest on 29 Oct 2026.
Next board meeting and results date
As the company gave notice to the exchange.Mangalam Drugs and Organics quarterly results
The board meets on 5 Nov 2026 to consider financial results and other business matters
Notice filed 29 Oct 2026
Mangalam Drugs and Organics annual reports, presentations and earnings calls
The company's own documents, latest first.Mangalam Drugs and Organics financials, year by year
Annual reports17
- Annual report, year to Mar 202631 Aug 2026
- Annual report, year to Mar 202510 Sep 2025
- Annual report, year to Mar 20244 Sep 2024
- Annual report, year to Mar 20236 Sep 2023, a zip file
- Annual report, year to Mar 20222 Sep 2022, a zip file
12 earlier reports
- Annual report, year to Mar 20212 Sep 2021, a zip file
- Annual report, year to Mar 20202 Sep 2020, a zip file
- Annual report, year to Mar 201930 Aug 2019, a zip file
- Annual report, year to Mar 201829 Sep 2018, a zip file
- Annual report, year to Mar 20174 Oct 2017, a zip file
- Annual report, year to Mar 20164 Oct 2016, a zip file
- Annual report, year to Mar 201518 Aug 2015, a zip file
- Annual report, year to Mar 201412 Sep 2014, a zip file
- Annual report, year to Mar 20133 Sep 2013, a zip file
- Annual report, year to Mar 201212 Oct 2012, a zip file
- Annual report, year to Mar 201120 Sep 2011, a zip file
- Annual report, year to Mar 201019 Apr 2011, a zip file
Investor presentations2
- Investor Presentation- August 2016.3 Aug 2016, a zip file
- Investor Presentation May 2016.24 May 2016, a zip file
Mangalam Drugs and Organics merger and demerger filings
Filings about a merger, demerger or scheme of arrangement, latest first.
Filings6
- Scheme of Arrangement16 Oct 2025
- Amalgamation/Merger15 Oct 2025
- Amalgamation/Merger9 Jul 2025
- Scheme of Arrangement18 Jun 2024
- Scheme of Arrangement16 Mar 2024
1 earlier filing
- Amalgamation/Merger16 Mar 2024
Mangalam Drugs and Organics share news and announcements
Newest first. Page 1 of 11.
Oct 2026
16 Oct · Legal
1 Oct · Meeting
Sep 2026
23 Sep · Meeting
15 Sep · Legal
15 Sep · Board meeting
Aug 2026
17 Aug · Legal
12 Aug · Management
12 Aug · Results
6 Aug
Jul 2026
16 Jul · Legal
Jun 2026
17 Jun · Legal
May 2026
18 May · Meeting
16 May · Legal
14 May · Results
Apr 2026
16 Apr · Legal
Mar 2026
26 Mar · Board meeting
24 Mar · Board meeting
17 Mar · Legal
Feb 2026
6 Feb · Board meeting
4 Feb · Board meeting
3 Feb · Rating
Jan 2026
17 Jan · Management
15 Jan · Results
15 Jan · Board meeting
7 Jan · Board meeting
7 Jan · Legal
The exchange asked on 5 Jan 2026
Dec 2025
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 13 Aug 2026Resultsup 1.91%+2.0 pts vs Nifty 500market median −0.7% · five sessions −1.2% (0.0 pts vs Nifty 500) · volume 2.6× usual · delivery −2.9 pts against usual · The announcement
- 15 May 2026Resultsdown 1.96%−1.6 pts vs Nifty 500market median −0.7% · five sessions −0.1% (−0.1 pts vs Nifty 500) · volume 0.8× usual · The announcement
- 17 Apr 2026Board or managers changedup 0.50%−0.4 pts vs Nifty 500market median 0.0% · five sessions −4.8% (−5.5 pts vs Nifty 500) · volume 1.2× usual · The announcement
- 4 Feb 2026Credit ratingdown 4.99%−5.4 pts vs Nifty 500market median 0.0% · five sessions −12.2% (−13.5 pts vs Nifty 500) · volume 0.7× usual · The announcement
- 19 Jan 2026Board or managers changedup 5.00%+5.5 pts vs Nifty 500market median 0.0% · five sessions −5.5% (−2.2 pts vs Nifty 500) · volume 0.5× usual · The announcement
- 16 Jan 2026Resultsup 4.98%+4.9 pts vs Nifty 500market median −0.7% · five sessions +4.4% (+6.4 pts vs Nifty 500) · volume 1.1× usual · The announcement
- 16 Jan 2026Board or managers changedup 4.98%+4.9 pts vs Nifty 500market median 0.0% · five sessions +4.4% (+6.4 pts vs Nifty 500) · volume 1.1× usual · The announcement
- 26 Dec 2025Board or managers changeddown 0.92%−0.6 pts vs Nifty 500market median 0.0% · five sessions +20.3% (+20.1 pts vs Nifty 500) · volume 0.3× usual · delivery −4.3 pts against usual · The announcement
- 19 Aug 2025Resultsup 0.90%+0.3 pts vs Nifty 500market median −0.7% · five sessions −0.9% (−1.5 pts vs Nifty 500) · volume 0.2× usual · delivery +19.7 pts against usual · The announcement
- 19 May 2025Resultsdown 3.22%−3.2 pts vs Nifty 500market median −0.7% · five sessions −1.0% (−0.6 pts vs Nifty 500) · volume 5.4× usual · delivery +14.4 pts against usual · The announcement
15 earlier announcements
- 1 Apr 2025Board or managers changedup 5.91%+7.2 pts vs Nifty 500market median 0.0% · five sessions −1.3% (+4.5 pts vs Nifty 500) · volume 0.3× usual · delivery −11.1 pts against usual · The announcement
- 16 Jan 2025Credit ratingdown 0.36%−1.1 pts vs Nifty 500market median 0.0% · five sessions −0.3% (+0.4 pts vs Nifty 500) · volume 0.6× usual · delivery +19.5 pts against usual · The announcement
- 28 Jun 2024Board or managers changedup 0.81%+0.7 pts vs Nifty 500market median 0.0% · five sessions +5.7% (+4.0 pts vs Nifty 500) · volume 1.2× usual · delivery −10.9 pts against usual · The announcement
- 14 Nov 2022Resultsdown 2.97%−3.0 pts vs Nifty 500market median −0.7% · five sessions −5.5% (−4.9 pts vs Nifty 500) · volume 1.1× usual · delivery −8.4 pts against usual · The announcement
- 29 Aug 2022Board or managers changeddown 1.18%0.0 pts vs Nifty 500market median 0.0% · five sessions −1.3% (−2.2 pts vs Nifty 500) · volume 0.6× usual · delivery −1.5 pts against usual · The announcement
- 7 Feb 2022Board or managers changeddown 2.07%−0.6 pts vs Nifty 500market median 0.0% · five sessions −6.6% (−5.3 pts vs Nifty 500) · volume 0.5× usual · delivery +3.9 pts against usual · The announcement
- 7 Dec 2020Board or managers changedup 1.96%+1.1 pts vs Nifty 500market median 0.0% · five sessions −1.2% (−2.9 pts vs Nifty 500) · volume 0.4× usual · delivery −2.8 pts against usual · The announcement
- 23 Nov 2020Board or managers changeddown 4.88%−5.6 pts vs Nifty 500market median 0.0% · five sessions −3.7% (−5.2 pts vs Nifty 500) · volume 1.6× usual · delivery +10.5 pts against usual · The announcement
- 27 Jan 2020Resultsup 4.92%+5.8 pts vs Nifty 500market median −0.7% · five sessions −3.1% (−0.9 pts vs Nifty 500) · volume 4.2× usual · delivery −11.4 pts against usual · The announcement
- 4 Nov 2019Resultsup 4.87%+4.6 pts vs Nifty 500market median −0.7% · five sessions −12.9% (−12.7 pts vs Nifty 500) · volume 0.7× usual · delivery +20.0 pts against usual · The announcement
- 22 May 2018Board or managers changedup 4.47%+4.1 pts vs Nifty 500market median 0.0% · five sessions −12.9% (−15.1 pts vs Nifty 500) · volume 1.1× usual · delivery −4.3 pts against usual · The announcement
- 12 Dec 2017Dividenddown 1.69%−0.9 pts vs Nifty 500market median 0.0% · five sessions −4.7% (−5.2 pts vs Nifty 500) · volume 0.8× usual · delivery −15.1 pts against usual · The announcement
- 4 Nov 2016Credit ratingdown 2.86%−1.9 pts vs Nifty 500market median 0.0% · five sessions +4.0% (+4.0 pts vs Nifty 500) · volume 0.7× usual · delivery −0.4 pts against usual · The announcement
- 6 Feb 2015Board or managers changeddown 2.58%−1.9 pts vs Nifty 500market median 0.0% · five sessions −6.7% (−7.2 pts vs Nifty 500) · volume 0.3× usual
- 31 May 2010Board or managers changedup 1.12%+0.2 pts vs Nifty 500market median 0.0% · five sessions +2.6% (+0.8 pts vs Nifty 500) · volume 0.1× usual
Mangalam Drugs and Organics results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Cash at the end of the period | At Sep 2025 | Standalone | 15.52 | 3.29 | −78.8% | 8 Dec 2025 | 19 Feb 2026 |
| Plant and property sold | Year to date to Sep 2025 | Standalone | −0.04 | 0.04 | +200.0% | 8 Dec 2025 | 19 Feb 2026 |
| Capital spending | Year to date to Sep 2025 | Standalone | −5.80 | 5.80 | +200.0% | 8 Dec 2025 | 19 Feb 2026 |
| Dividends received | Year to date to Sep 2025 | Standalone | 0.00 | 0.00 | +200.0% | 8 Dec 2025 | 19 Feb 2026 |
| Cash from investing | Year to date to Sep 2025 | Standalone | 5.76 | −5.76 | −200.0% | 8 Dec 2025 | 19 Feb 2026 |
| Net change in cash, before currency effects | Year to date to Sep 2025 | Standalone | 12.23 | 0.72 | −94.1% | 8 Dec 2025 | 19 Feb 2026 |
| Net change in cash | Year to date to Sep 2025 | Standalone | 12.95 | 0.72 | −94.5% | 8 Dec 2025 | 19 Feb 2026 |
| Diluted earnings per share | Quarter to Mar 2025 | Standalone | 0.10 | 0.20 | +100.0% | 18 May 2025 | 12 Jun 2025 |
| Intangible assets | At Mar 2025 | Standalone | 29.14 | 29.14 | 0.0% | 18 May 2025 | 12 Jun 2025 |
| Assets held for longer than a year | At Mar 2025 | Standalone | 160.25 | 160.25 | 0.0% | 18 May 2025 | 12 Jun 2025 |